|
Mr. Garnet has 30 years of experience as a research analyst specializing in biotechnology and healthcare. He began his career at McKinsey & Co. as a consulting associate while attending the Harvard School of Business. He then headed the M&A group at W.R. Grace & Co where his responsibilities included the identification and acquisition of companies in emerging industries. In 1989, Mr. Garnet served as a Stock Analyst for Value Line, Inc. where he followed and evaluated equities in industries such as semiconductors, oil, oilfield services, coal/alternate energy, steel, retail and restaurant industries. In 1990, Andre served as a research analyst for Prudential Securities, specializing in biotechnology. He then served as Senior Healthcare Analyst at SouthCoast Capital Corp. where his biotech equity research built a large following amongst institutional investors. Andre was the Vice President of A.G. Edwards & Sons, Inc. between 1993 and 1996 where he conducted research as a Senior Biotechnology analyst, successfully launching coverage of this industry during one of its down-cycles. His stock picks attracted a large following amongst institutional and retail investors where he tied for first place in biotechnology in a quarterly ranking of brokerage firms performed by the Wall Street Journal. At Ladenburg, Thalmann & Co., Mr. Garnet was responsible for coverage of healthcare and biotechnology companies where his stock picks achieved highest price appreciation in the industry and generated excellent returns for institutional clients. Andre Garnet holds a M.S in Biochemistry from the University de Liege in Belgium, a M.B.A degree in Finance from Pace University in New York, New York, as well as a D.B.A in International Business from the Harvard Business School in Boston, Massachusetts. | 